{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:22:24Z","timestamp":1790036544473,"version":"4.0.1"},"reference-count":103,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-133680"],"award-info":[{"award-number":["MOP-133680"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000145","name":"Alberta Innovates\u2014Health Solutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000264","name":"Canadian Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec\u2014Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2016.00628","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T16:44:49Z","timestamp":1482511489000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Type III Interferons in Hepatitis C Virus Infection"],"prefix":"10.3389","volume":"7","author":[{"given":"Maude","family":"Boisvert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa H.","family":"Shoukry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors \u2013 distribution and regulation","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/hep.21312","article-title":"Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes","volume":"44","author":"Doyle","year":"2006","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","article-title":"IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo","volume":"4","author":"Sommereyns","year":"2008","journal-title":"PLoS Pathog"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e44915","DOI":"10.1371\/journal.pone.0044915","article-title":"Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells","volume":"7","author":"Dolganiuc","year":"2012","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.4049\/jimmunol.1102038","article-title":"Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells","volume":"189","author":"Yin","year":"2012","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1053\/jhep.2002.36227","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jare.2014.11.004","article-title":"New era for management of chronic hepatitis C virus using direct antiviral agents: a review","volume":"6","author":"Elbaz","year":"2015","journal-title":"J Adv Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2010.07.009","article-title":"A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin","volume":"139","author":"Swain","year":"2010","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int J Med Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2217\/pgs.09.121","article-title":"Host genetic determinants of spontaneous hepatitis C clearance","volume":"10","author":"Rauch","year":"2009","journal-title":"Pharmacogenomics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0027-9684(15)30948-2","article-title":"Treatment options for hepatitis C and the rationale for low response rates in African Americans","volume":"101","author":"Manka","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"issue":"1586\u20131592","key":"B22","doi-asserted-by":"publisher","first-page":"1592e1581","DOI":"10.1053\/j.gastro.2010.07.005","article-title":"A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice","volume":"139","author":"Tillmann","year":"2010","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/infdis\/jiv220","article-title":"Hepatitis C virus reinfection and spontaneous clearance of reinfection \u2013 the InC3 study","volume":"212","author":"Sacks-Davis","year":"2015","journal-title":"J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1089\/jir.2013.0136","article-title":"IFN-lambda4: the paradoxical new member of the interferon lambda family","volume":"34","author":"O\u2019Brien","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-DeltaG allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jhep.2015.06.035","article-title":"Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance","volume":"63","author":"O\u2019Brien","year":"2015","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/hep.25897","article-title":"IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection","volume":"56","author":"Park","year":"2012","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon-lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/jir.2013.0005","article-title":"Lambda interferon serum levels in patients with chronic hepatitis C virus infection according to their response to therapy with pegylated interferon and ribavirin","volume":"34","author":"Torres","year":"2014","journal-title":"J Interferon Cytokine Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/iid3.122","article-title":"IFN-lambda3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection","volume":"4","author":"Depla","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1038\/emboj.2013.232","article-title":"Interferon lambda 4 signals via the IFNlambda receptor to regulate antiviral activity against HCV and coronaviruses","volume":"32","author":"Hamming","year":"2013","journal-title":"EMBO J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0117397","DOI":"10.1371\/journal.pone.0117397","article-title":"IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients","volume":"10","author":"Bordi","year":"2015","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: identifying molecular pathways for treatment response","volume":"46","author":"Feld","year":"2007","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/gut.2007.128611","article-title":"Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C","volume":"57","author":"Asselah","year":"2008","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1073\/pnas.1513341112","article-title":"Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness","volume":"112","author":"Sung","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1038\/ncomms6699","article-title":"Reduced IFNlambda4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes","volume":"5","author":"Terczynska-Dyla","year":"2014","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"B45","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures","volume":"54","author":"Marukian","year":"2011","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.chom.2014.01.007","article-title":"Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness","volume":"15","author":"Sheahan","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1089\/jir.2014.0161","article-title":"Expression of interferon lambda 4 is associated with reduced proliferation and increased cell death in human hepatic cells","volume":"35","author":"Onabajo","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ajpath.2015.11.027","article-title":"Cellular mechanism for impaired hepatitis C virus clearance by interferon associated with IFNL3 gene polymorphisms relates to intrahepatic interferon-lambda expression","volume":"186","author":"Ferraris","year":"2016","journal-title":"Am J Pathol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/infdis\/jiu016","article-title":"Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels","volume":"209","author":"Jouvin-Marche","year":"2014","journal-title":"J Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/jvh.12040","article-title":"Induction of interferon-lambda contributes to toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes","volume":"20","author":"Wang","year":"2013","journal-title":"J Viral Hepat"},{"key":"B51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cytogfr.2010.04.002","article-title":"IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties","volume":"21","author":"Witte","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1182\/blood-2010-07-298976","article-title":"IL-29 and IFNalpha differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNgamma receptor expression","volume":"117","author":"Liu","year":"2011","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0162068","DOI":"10.1371\/journal.pone.0162068","article-title":"IL-28B genetic variants determine the extent of monocyte-induced activation of NK cells in hepatitis C","volume":"11","author":"Kramer","year":"2016","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1053\/j.gastro.2011.08.025","article-title":"A view to natural killer cells in hepatitis C","volume":"141","author":"Shoukry","year":"2011","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1001092","DOI":"10.1371\/journal.pmed.1001092","article-title":"IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study","volume":"8","author":"Suppiah","year":"2011","journal-title":"PLoS Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/hep.24556","article-title":"Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C","volume":"54","author":"Golden-Mason","year":"2011","journal-title":"Hepatology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1073\/pnas.1016358108","article-title":"Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection","volume":"108","author":"Dring","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"E521","DOI":"10.1073\/pnas.1109288108","article-title":"Reply to Kr\u00e4mer et al.: human natural killer (NK) cell inhibition by IL28A","volume":"108","author":"Gardiner","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/1753425913503385","article-title":"IFNL3 mediates interaction between innate immune cells: implications for hepatitis C virus pathogenesis","volume":"20","author":"O\u2019Connor","year":"2014","journal-title":"Innate Immun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"E519","DOI":"10.1073\/pnas.1108850108","article-title":"Do lambda-IFNs IL28A and IL28B act on human natural killer cells?","volume":"108","author":"Kramer","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B62","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/eji.201444903","article-title":"IFN-lambda-mediated IL-12 production in macrophages induces IFN-gamma production in human NK cells","volume":"45","author":"de Groen","year":"2015","journal-title":"Eur J Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.humimm.2014.06.016","article-title":"IFNL cytokines do not modulate human or murine NK cell functions","volume":"75","author":"Morrison","year":"2014","journal-title":"Hum Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"E2376","DOI":"10.1073\/pnas.1424241112","article-title":"NK cells require IL-28R for optimal in vivo activity","volume":"112","author":"Souza-Fonseca-Guimaraes","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1189\/jlb.4A1014-520R","article-title":"Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism","volume":"98","author":"Rogalska-Taranta","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1003316","DOI":"10.1371\/journal.ppat.1003316","article-title":"Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells","volume":"9","author":"Stone","year":"2013","journal-title":"PLoS Pathog"},{"key":"B67","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1365-2893.2012.01631.x","article-title":"IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors","volume":"19","author":"Bes","year":"2012","journal-title":"J Viral Hepat"},{"issue":"10","key":"B68","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/jvh.12560","article-title":"Breadth of the HCV-specific CD4+ T-cell response in spontaneous resolvers is independent of the IL-28 haplotype","volume":"23","author":"Scheurich","year":"2016","journal-title":"J Viral Hepat"},{"key":"B69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7326\/0003-4819-158-4-201302190-00003","article-title":"Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts","volume":"158","author":"Duggal","year":"2013","journal-title":"Ann Intern Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2013-306287","article-title":"Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection","volume":"64","author":"Fitzmaurice","year":"2015","journal-title":"Gut"},{"key":"B71","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/sj.gene.6364348","article-title":"Human interferon lambda-1 (IFN-lambda1\/IL-29) modulates the Th1\/Th2 response","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2567.2008.02862.x","article-title":"Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro","volume":"125","author":"Srinivas","year":"2008","journal-title":"Immunology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1182\/blood-2008-09-179507","article-title":"IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells","volume":"113","author":"Dai","year":"2009","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/infdis\/jir835","article-title":"Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion","volume":"205","author":"Raghuraman","year":"2012","journal-title":"J Infect Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.virol.2013.05.037","article-title":"Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection","volume":"444","author":"Esteban-Riesco","year":"2013","journal-title":"Virology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B80","doi-asserted-by":"publisher","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1086\/383279","article-title":"Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort","volume":"189","author":"Post","year":"2004","journal-title":"J Infect Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1743-422X-4-58","article-title":"Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response","volume":"4","author":"Meyer","year":"2007","journal-title":"Virol J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1189\/jlb.3A0215-041RR","article-title":"IFN-lambda is able to augment TLR-mediated activation and subsequent function of primary human B cells","volume":"98","author":"de Groen","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e1004556","DOI":"10.1371\/journal.ppat.1004556","article-title":"IL-28B is a key regulator of B- and T-cell vaccine responses against influenza","volume":"10","author":"Egli","year":"2014","journal-title":"PLoS Pathog"},{"key":"B85","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0168-8278(00)80075-6","article-title":"Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C","volume":"32","author":"Gervais","year":"2000","journal-title":"J Hepatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/j.1471-0528.2000.tb11675.x","article-title":"Hepatitis C virus load during pregnancy and puerperium","volume":"107","author":"Lin","year":"2000","journal-title":"BJOG"},{"key":"B87","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1073\/pnas.1602337113","article-title":"Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery","volume":"113","author":"Honegger","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B88","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri3361","article-title":"Mechanisms of T cell tolerance towards the allogeneic fetus","volume":"13","author":"Erlebacher","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0167-5699(98)01393-0","article-title":"An innate view of human pregnancy","volume":"20","author":"Sacks","year":"1999","journal-title":"Immunol Today"},{"key":"B90","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ni1037","article-title":"Regulatory T cells mediate maternal tolerance to the fetus","volume":"5","author":"Aluvihare","year":"2004","journal-title":"Nat Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10678","DOI":"10.1073\/pnas.1602319113","article-title":"Prolonged activation of innate antiviral gene signature after childbirth is determined by IFNL3 genotype","volume":"113","author":"Price","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B92","doi-asserted-by":"publisher","first-page":"608-618.e601","DOI":"10.1053\/j.gastro.2012.05.011","article-title":"Factors that predict response of patients with hepatitis C virus infection to boceprevir","volume":"143","author":"Poordad","year":"2012","journal-title":"Gastroenterology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"ofu110","DOI":"10.1093\/ofid\/ofu110","article-title":"Subgroup differences in response to 8 weeks of ledipasvir\/sofosbuvir for chronic hepatitis C","volume":"1","author":"O\u2019Brien","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","author":"European Association for Study of Liver","year":"2015","journal-title":"J Hepatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.jhep.2016.07.037","article-title":"Host \u2013 hepatitis C viral interactions: the role of genetics","volume":"65","author":"Heim","year":"2016","journal-title":"J Hepatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/hep.26506","article-title":"Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2014.11.002","article-title":"Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study","volume":"113","author":"Bruno","year":"2015","journal-title":"Antiviral Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/hep.24678","article-title":"IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes","volume":"55","author":"Bochud","year":"2012","journal-title":"Hepatology"},{"key":"B99","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1038\/ncomms7422","article-title":"Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease","volume":"6","author":"Eslam","year":"2015","journal-title":"Nat Commun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jhep.2010.07.019","article-title":"IL-28B rs12979860 C\/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC","volume":"54","author":"Fabris","year":"2011","journal-title":"J Hepatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.cgh.2014.10.035","article-title":"A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection","volume":"13","author":"Chang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.humimm.2011.12.021","article-title":"Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection","volume":"73","author":"Joshita","year":"2012","journal-title":"Hum Immunol"},{"issue":"12","key":"B103","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1084\/jem.20160437","article-title":"Interferon lambda 4 expression is suppressed by the host during viral infection","volume":"213","author":"Hong","year":"2016","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00628\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T16:44:54Z","timestamp":1482511494000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2016.00628\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":103,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2016.00628","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}